LEADER 01435nam  2200433   450 
001 9910156360503321
005 20171028091901.0
010   $a1-5361-0253-9
035   $a(CKB)3710000000985543
035   $a(MiAaPQ)EBC4789215
035   $a(EXLCZ)993710000000985543
100   $a20160916h20172017  uy|            0
101 0 $aeng
135   $aurcnu||||||||
181   $2rdacontent
182   $2rdamedia
183   $2rdacarrier
200 00$aClinical aspects of psychopharmacology in childhood and adolescence /$fDonald E. Greydanus [and four others], editors
205   $aSecond edition.
210  1$aHauppauge, NY :$cNova Science Publishers, Incorporated,$d[2017]
210  4$dİ2017
215   $a1 online resource (341 pages) $cillustrations
225 1 $aPediatrics, child and adolescent health
311   $a1-5361-0241-5 
320   $aIncludes bibliographical references and index.
410  0$aPediatrics, child and adolescent health.
606   $aPediatric psychopharmacology
606   $aAdolescent psychopharmacology
615  0$aPediatric psychopharmacology.
615  0$aAdolescent psychopharmacology.
676   $a615.780835
702   $aGreydanus$b Donald E.
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910156360503321
996   $aClinical aspects of psychopharmacology in childhood and adolescence$92895590
997   $aUNINA